Septerna, Inc. (SEPN)
NASDAQ: SEPN · Real-Time Price · USD
42.60
+0.74 (1.77%)
Nov 13, 2026, 4:00 PM EST - Market closed
Septerna Market Cap
Septerna has a market cap or net worth of $2.03 billion as of November 13, 2026. It is the 6,470th most valuable company in the world and the 1,740th biggest in the United States. Its market cap has increased by 135.26% in one year.
Market Cap
2.03B
Enterprise Value
1.48B
1-Year Change
135.26%
Global Rank
Country Rank
#1,740 United States
Category
ChartMarket Cap Chart
Since the IPO on October 25, 2024, Septerna's market cap has increased from $756.05M to $2.03B, an increase of 167.92%. That is a compound annual growth rate of 61.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 2.03B | 62.27% |
| Dec 31, 2025 | 1.25B | 22.77% |
| Dec 31, 2024 | 1.02B | 34.49% |
| Oct 25, 2024 | 756.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lakefront Biotherapeutics NV | 2.13B |
| Aurinia Pharmaceuticals | 2.11B |
| Biohaven | 2.09B |
| Replimune Group | 2.08B |
| Vera Therapeutics | 2.03B |
| Recursion Pharmaceuticals | 1.99B |
| Harmony Biosciences Holdings | 1.98B |
| First Tracks Biotherapeutics | 1.98B |